noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Meritex Co

Meritex Welcomes Summer Intern Viransh Yadav to Minneapolis Headquarters
Marquette University

Marquette wins three Collegiate Advertising Awards
Marquette University

Summer is an ideal time for dental visits; preventive services at[...]

Healthcare

OraSure Technologies Inc.

06/11/2026 | Press release | Distributed by Public on 06/11/2026 07:02

Material Event (Form 8-K)

Item 8.01 Other Events.

On June 11, 2026, OraSure Technologies, Inc. (the "Company") announced U.S. Food and Drug Administration ("FDA") clearance of the Company's Colli-Pee™•Dx Urine Collection Kit from its subsidiary DNA Genotek Inc., for use with Roche Molecular Systems, Inc. ("Roche") tests for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium and run on Roche's cobas® 5800, 6800, and 8800 molecular diagnostic systems. The FDA-cleared collection kit supports at-home self-collection of first-void urine, enabling convenient at-home sample collection for both male and female patients.

OraSure Technologies Inc. published this content on June 11, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 11, 2026 at 13:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]